Replies to @jeffmarc Another thing that caught my attention was that the researchers were seeing coronary plaque progression...

← Return to new study on cardiovascular risk of ADT

Discussion

Prostate Cancer | Last Active: May 8 6:10am | Replies (16)

Comment receiving replies

@melvinw

Another thing that caught my attention was that the researchers were seeing coronary plaque progression within only 12 months of ADT therapy.

I hope this study gets attention with oncologists, despite the fact that it was published in a cardiology journal. I suspect the researchers will give several talks and presentations to reach a wider audience. But hopefully sharing it here too will raise awareness. I know the lower cardiovascular risk of Orgovyx has been discussed several times in the forum, but this study really provides sound scientific evidence for that.

Jump to this post

Replies to "@jeffmarc Another thing that caught my attention was that the researchers were seeing coronary plaque progression..."

Jeff Marchi | @jeffmarc | May 6 8:38pm

@melvinw
I was on Lupron for six years and when I had scans, they told me I had arterial sclerosis. I didn’t realize that Lupron not only created it but being on it so long could have make it so much worse. I’ve had some minor heart issues according to my cardiologist, Skipped beats, double beats going on for a long periods of time. Since I don’t have any Fatigue or pain it’s not something they treat. Lupron must be the culprit.

I have always had very low cholesterol, Something that supposed to help. I also exercise a lot another thing that’s supposed to help. I don’t want a heart attack to be my solution to prostate cancer.

I made the right decision moving to Orgovyx three years ago.

VIEW AND REPLY